home / subscribe / donate / tower / books / archives / search / links / feedback / events
![]() |
|
Get the Answer Only in CounterPunch's Print Edition US's top radical economist, Prof.Robert Pollin, gives CounterPunch newsletter subscribers exclusive briefing on the global casino and the dollar's future. Is neoliberalism still calling the shots? Is US now under Chinese rule? Move over, Kansas! Maybe Tom Frank got it wrong. Roxanne Dunbar-Ortiz asks, What's the matter with Oklahoma? How did one state go from pro-worker to proto-fascist in a generation? It'll take a mutiny: Alexander Cockburn on how Cindy Sheehan and a radical movement can end the war. Get the answers you're looking for in the latest subscriber-only edition of CounterPunch ... CounterPunch Online is read by millions of viewers each month! But remember, we are funded solely by the subscribers to the print edition of CounterPunch. Please support this website by buying a subscription to our newsletter, which contains fresh material you won't find anywhere else, or by making a donation for the online edition. Remember contributions are tax-deductible. Click here to make a donation. If you find our site useful please: Subscribe Now! or write CounterPunch, PO BOX 228, Petrolia, CA 95558 |
|
September 9 / 11, 2005 Col.
Dan Smith Col.
Douglas A. Macgregor
September 8, 2005 John
Chuckman Dan
La Botz Carol
Norris David
Krieger Irma
Thomas Roger
Morris September 7, 2005 Roxanne
Dunbar-Ortiz Werther Chris
Floyd Jason
Leopold Michael
Donnelly Niranjan
Ramakrishnan Linda
Milazzo / John Stern Gary
Leupp Pierre
Tristam Kevin
Zeese Charmaine
Neville
September 6, 2005 Keeanga-Yamahtta
Taylor Dan
La Botz Larry
Bradshaw / Lorrie Beth Slonsky Chuck
D. Debbie
Dupre / Bill Quigley Omar
Wariach Mike
Whitney Carol
Norris Norman
Solomon Michael
Neumann
Paul
Craig Roberts David
Vest John
Blair Fidel
Castro Mike
Whitney Alan
Farago Doug
Giebel Mark
Chmiel Carol
Wolman, MD Norman
Solomon Eli
Stephens Peter
Linebaugh
September 3 / 4, 2005 Alexander
Cockburn Paul
Craig Roberts Gary
Leupp Dave
Lindorff Dan
La Botz Jonathan
M. Feldman Landau
/ Hassen Tim
Wise Mitchel
Cohen Dave
Zirin Mike
Ferner Rep.
Cynthia McKinney Jason
Leopold Justin
Felux Monica
Benderman Ben
Tripp Jordan
Flaherty Bill
Pahnelas Seth
Sandronsky Mark
Donham Fred
Gardner Joshua
Frank Jackie
Corr Poets'
Basement
September 2, 2005 Evan
Jones David
Stocker Dave
Lindorff Norman
Solomon Mike
Whitney Eli
Stephens Ron
Jacobs Christopher
Brauchli Harvey
Wasserman CounterPunch
Wire Glen
Ford
September 1, 2005 Dr.
Greg Henderson, MD Paul
Craig Roberts Mike
Whitney Lee
Sustar Dave
Lindorff Lynn
Gonzalez Chris
Floyd
Cockburn
/ St. Clair John Walsh Bernstein /
Mishel Alan Farago Norman
Solomon Bryan
Newbury Jason
Leopold Website
of the Day
August 30, 2005 Gary
Leupp Joshua
Frank Evelyn
Pringle Urariano
Mota Ron
Jacobs CP
News Service Roger
Morris
August 29, 2005 Seth
Sandronsky Norman
Solomon Charles
Sullivan Paul
Craig Roberts Website
of the Day
Alexander
Cockburn Ricardo
Alarcon Diane
Christian M.
Shahid Alam Laith
al-Saud Diane
Farsetta Saul
Landau Tom
Barry Nicholas
Rowe George
E. Bisharat Dave
Lindorff Fred
Gardner John
Francis Lee Evan
Jones Ali
Khan Poets'
Basement August 26, 2005 Lee
Sustar Ramzy
Baroud Christopher
Brauchli Peter
Harley John
Snider Kathleen
Christison
August 25, 2005 Paul
Craig Roberts Cockburn
/ St. Clair J.L.
Chestnut, Jr. Chhandasi
Pandya Richard
Ward Norman
Solomon Joshua
Frank Seth
Sandronsky Lucinda
Marshall VIPS Ralph
Nader
August 24, 2005 Stan
Goff Rachard
Itani Elisa
Salasin Ron
Jacobs John
Chuckman Leibowitz
/ Heller Douglas
Valentine Thomas
Nagy Alexander
Cockburn Website
of the Day
August 23, 2005 Rev.
Graylan Scott Hagler Karen
Kilroy Stew
Albert Joshua
Frank Dave
Zirin Julia
Olmstead CounterPunch
Wire Jason
Leopold Diane
Christian
August 22, 2005 Sonia
Nettnin Mike
Whitney Kevin
Zeese Norman
Solomon Christopher
Brauchli Jeff
Bale Greg
Moses
August 20 / 21, 2005 Alexander
Cockburn Saul
Landau Kevin
Zeese Greg
Moses Ray
McGovern Fred
Gardner Martin
Smith Benjamin
Granby Frankie
Lake Joshua
Frank Ron
Jacobs Tom
Crumpacker Mike
Ferner James
Petras Col.
Dan Smith Dr.
Teresa Whitehurst Ben
Tripp Poets'
Basement
August 19, 2005 Alexander
Cockburn Neve
Gordon Gary
Leupp William
S. Lind Vijay
Prashad Dave
Lindorff Pat
Williams John
Pilger Elaine
Cassel
August 18, 2005 Alexander
Cockburn Greg
Moses Ramzy
Baroud Joshua
Frank Monica
Benderman Paul
Craig Roberts
August 17, 2005 Alexander
Cockburn Robert
Jensen Carl
G. Estabrook Mike
Whitney Niranjan
Ramakrishnan Norman
Solomon Dave
Zirin Jennifer
Loewenstein CounterPunch
August 16, 2005 Greg
Moses Thomas
Larson Diana
Barahona Dave
Lindorff Rep.
Cynthia McKinney Elisa
Salasin David
Krieger Alexander
Cockburn Website
of the Day
August 15, 2005 Greg
Moses Paul
Craig Roberts Mike
Whitney Robert
Jensen CounterPunch
Wire Norman
Solomon Kathleen
Christison
August 13 / 14, 2005 Cockburn
/ St. Clair William
Blum Gary
Leupp Jack
Z. Bratich Brian
Cloughley Ron
Jacobs John
Farley Dave
Lindorff Tim
Wise J.L.
Chestnut, Jr. John
Gershman Felice
Pace Fred
Gardner David
Krieger Roxanne
Dunbar-Ortiz Ben
Tripp Poets'
Basement
August 12, 2005 Christopher
Brauchli Greg
Moses Ramzy
Baroud Norman
Solomon Chris
Genovali Chris
Floyd Tariq
Ali
August 11, 2005 Saul
Landau Dave
Lindorff Ralph
Nader Talli
Nauman Gary
Leupp Sharon
Smith Paul
Craig Roberts
August 10, 2005 Tim
Wise Ron
Jacobs Joshua
Frank Cynthia
McKinney Rick
Wilhelm Stan
Goff
August 9, 2005 Mike
Ferner Monica
Benderman Mike
Marqusee Rep.
Cynthia McKinney Paul
Craig Roberts
August 6-8, 2005 Alexander
Cockburn Jason
Leopold Ray
McGovern David
Krieger Sharon
K. Weiner / Robert Jensen Fred
Gardner
August 5, 2005 Bill
Christison Paul
Craig Roberts Alexander
Cockburn
August 4, 2005 Tom
Barry Lila
Rajiva Greg
Moses Alexander
Cockburn August 3, 2005
August 3, 2005 Alexander
Cockburn Paul
Craig Roberts William
A. Cook Dave
Zirin Dave
Lindorff José
Pertierra
August 2, 2005 Ramzi
Kysia William
A. Cook Paul
Craig Roberts Mike
Whitney Ron
Jacobs Norman
Madarsz Tim
Wise
August 1, 2005 Virginia
Rodino Diana
Barahona Joshua
Frank Mike
Whitney Norm
Dixon Norman
Solomon James
Petras
July 30 / 31, 2005 Alexander
Cockburn JoAnn
Wypijewski Sheldon
Rampton Jack
Z. Bratich Greg
Moses Jordan
Green Patrick
Cockburn Brian
Cloughley Justin
Taylor Saul
Landau John
Walsh Joshua
Frank Ron
Jacobs Fred
Gardner John
Chuckman Liaquat
Ali Khan Remi
Kanazi Naveen
Jaganathan Richard
Heinberg Max
Watts Ben
Tripp Poets'
Basement
July 29, 2005 Cockburn
/ St. Clair P.
Sainath Niranjan
Ramakrishnan Dave
Lindorff J.L.
Chestnut, Jr. Pat
Williams Norman
Solomon Sen.
Russ Feingold
July 28, 2005 Paul
Craig Roberts William
S. Lind Gilad
Atzmon Joshua
Frank Lila
Rajiva Amina
Mire Website
of the Day
July 27, 2005 Roger
Morris Gary
Leupp Paul
Craig Roberts Jackie
Corr Mike
Whitney Dave
Zirin Christopher
Bradley Norman
Solomon Website
of the Day
July 26, 2005 Suren
Pillay JoAnn
Wypijewski Patrick
Cockburn David
Anderson Joshua
Frank Lenni
Brenner David
Swanson
July 25, 2005 Paul
Craig Roberts M.
Shahid Alam Uri
Avnery Stan
Cox Norman
Solomon Ramzy
Baroud Mickey
Z. Website
of the Day
July 23 / 24, 2005 Alexander
Cockburn Tariq
Ali Robert
Fisk Dave
Lindorff Ricardo
Alarcón Col.
Dan Smith Brian
Cloughley Kevin
Zeese Bill
Quigley Fred
Gardner Rep.
Ron Paul Joshua
Frank Shivali
Tukdeo Gilad
Atzmon James
Petras Ben
Tripp Poets'
Basement Website
of the Weekend
July 22, 2005 Heather
Gray David
Domke Lance
Selfa JoAnn
Wypijewski
July 21, 2005 Rose
Ann DeMoro William
Blum J.L.
Chestnut, Jr. Christopher
Brauchli Joshua
Frank Brian
Concannon, Jr. Patrick
Cockburn Website
of the Day
July 20, 2005 Cockburn
/ St. Clair Roxanne
Dunbar-Ortiz Ray
McGovern Chris
Floyd Uri
Avnery Dave
Lindorff Norman
Solomon Bill
Quigley
July 19, 2005 Tariq
Ali John
Ross Davey
D. Greg
Weiher Brian
McKinlay Norman
Solomon Dave
Lindorff Bill
Christison Joshua
Frank
July 18, 2005 Joshua
Frank M.
Shahid Alam Jude
Wanniski Ron
Jacobs Mike
Whitney William
MacDougall Seth
Sandronsky Richard
Lichtman Paul
Craig Roberts Website
of the Weekend
July 15 / 17, 2005 Alexander
Cockburn Jeffrey
St. Clair Paul
Craig Roberts Harry
Browne Uri
Davis, Ilan Pappe and Tamar Yaron Andrew
Rubin Patrick
Cockburn J.L.
Chestnut, Jr. Fred
Gardner Christopher
Brauchli Chris
Floyd Ben
Tripp Col.
Dan Smith Jason
Leopold Jack
Random Norman
Solomon George
Ochenski Website
of the Weekend
July 14, 2005 Jeffrey
St. Clair Subcomandante
Marcos Dave
Lindorff Joshua
Frank Jude
Wanniski Dave
Zirin Kevin
Zeese Robert
Jensen Reza
Fiyouzat Carol
Norris Website
of the Day
July 13, 2005 Brian
Cloughley George
Galloway Carlos
Fierro Sarah
Knopp Norman
Solomon Mickey
Z. Jim
Minick Pat
Williams Andrew
N. Rubin Website
of the Day
July 12, 2005 Laith
al-Saud Kara
N. Tina William
A. Cook Jack
Bratich Amina
Mire Dick
J. Reavis Kevin
Zeese Paul
Craig Roberts Website
of the Day
July 9 / 11, 2005 Alexander
Cockburn Uri
Avnery Sheldon
Rampton Bill
Christison Robert
Fisk Stephen
Winspear Saul
Landau Behrooz
Ghamari Karl
Beitel Brian
Concannon, Jr. Fred
Gardner John
Whitlow Niranjan
Ramakrishnan Lila
Rajiva Laura
Carlsen Jackie
Corr Dave
Lindorff N.
D. Jayaprakash Seth
Sandronsky Norman
Madarasz Ben
Tripp Poets'
Basement Website
of the Weekend
July 8, 2005 Paul
Craig Roberts Tariq
Ali Monica
Benderman Rick
Jahnkow Christopher
Brauchli Kim
Peterson Joshua
Frank Norman
Solomon Website
of the Day
July 7, 2005 Cockburn
/ St. Clair John
Walsh Mike
Marqusee Gilad
Atzmon Nicole
Colson Jack
Random Norman
Solomon Len
Colodny Cockburn
/ St. Clair
Subscribe Online
|
September 9, 2006 Pot ShotsMarijuana Might Really Make You CoolBy FRED GARDNER Marijuana use may confer health benefits by lowering overall body temperature, according to Tod Mikuriya, MD. It has been observed by his office staff -and confirmed anecdotally by colleagues- that people seeking physician approval to medicate with cannabis usually register body temperatures markedly below 98.6. Just as lower calorie consumption is associated with greater longevity, lower temperature could confer an advantage by slowing down metabolism! (Sometimes "great ideas" are simple and obvious. For example, all history is the story of class struggle, and, in addition to the thoughts we're aware of, we have unconscious thoughts that can be glimpsed in dreams.) Mikuriya writes in the new O'Shaughnessy's:
There's many a pothead thinks their drug of choice makes them cooler than the general population. Wait till they find out how much cooler! O'Shaughnessy's is the journal of sorts that I produce for California's small but growing group of pro-cannabis doctors. It is not available by subscription, but a contribution of any amount to the CCRMG (California Cannabis Research Medical Group) will get you on the mailing list for Fall '05 and future issues. The CCRMG is a 501(c)3 non-profit; contributions are tax deductible. It was founded in 1999 by Mikuriya, whose pioneering clinical research has been rewarded by the Medical Board of California with a $75,000 fine (to pay for the cost of his own prosecution; the liberal equivalent of being made to dig your own grave). The CCRMG is not supported by a generous grant from MPP, Green Aid, DPA and other reform bureaucracies. It is BY FAR the best way to support the medical marijuana movement (as opposed to the medical marijuana industry, which does not really need external support). Please send what you can to CCRMG, po box 9143, Berkeley CA 94709 But wait, there's more! If you order now, you'll also receive a never-before published transcript of the 1937 Congressional Hearing that led to the Prohibition of Marijuana, with commentary by your correspondent. Two more nuggets from the new O'Shaughnessy's follow. Enter THC-V (tetrohydrocannabivarin) The big news at this year's meeting of the International Cannabinoid Research Society, as reported on Counterpunch.org, the Anderson Valley Advertiser, and almost nowhere else, alas, was the conclusion by Donald Tashkin, MD, and colleagues at UCLA that marijuana smoking -"even heavy, longterm use"- does not cause cancer of the lung, upper airways, or esophagus. Among the other talks of apparent significance was one by Roger Pertwee, MD, of the University of Aberdeen, who described experiments using a cannabis strain bred by G.W. Pharmaceuticals to be high in THC-V (tetrohydrocannabivarin). It turns out that THCV strongly antagonizes anandamide -one of the body's own cannabinoids- while hardly antagonizing the plant cannabinoid THC! It's as if the cannabis plant contains and makes available to the body a choice of drugs and the body uses those it needs to achieve a balanced state (homeostasis). If the body is producing endocannabinoids in excess, it can use the plant cannabinoid THC-V to achieve homeostasis. If the endocannabinoid system needs a boost, the THC provides it (while the THC-V shuts down the endocannabinoid system, giving it a rest as it were). The key to relief, apparently, is not high cannabinoid levels but proper gradients. Geoffrey Guy, MD, expounded in an interview: "It's as if the plant contains a first-aid kit giving the body everything it needs to get bettter, and the body decides which components to employ... The endocannibnoid system begins to kick in in abnormality, in pathology. Perhaps it kicks in whether the pathology is an increase in something or a decrease in something. What it's trying to do is get whatever that abnormality is back to homeostasis.
Which might explain the apparent benignity of Rimonabant, a drug that works by blocking the CB1 receptor system. Rimonabant is being tested by Sanofi-Aventis for weight loss and smoking cessation. Originally known as SR-141716, it was developed in the early 1990s as an antagonist drug for use by researchers. At the 2004 ICRS meeting, Sanofi researchers described favorable results from clinical trials of Rimonabant as a diet drug. They informally predicted regulatory approval in Europe and the U.S. within a year. Some observers warned that blocking the CB1 receptor system could result in unforeseen longterm side effects and noted that at least one MS patient had experienced an exacerbation after taking Rimonabant. Although regulatory approval has not yet been granted, Sanofi reported good news at the 2005 meeting regarding side-effects: no more MS cases in a smoking-cessation study study involving more than 1,000 patients worldwide. "Both the 5mg and 20mg doses continued to show efficacy in the maintenance of abstinence from smoking," reported Gerard Le Fur. "The 20mg dose also demonstrated efficacy in the reduction of weight gain as well as significantly increasing the HDL-Cholesterol levels." A Sanofi team also reported favorable results from studies using Rimonabant to treat various rodent models of "metabolic syndrome" -obesity-related high blood pressure, high insulin levels, excessive triglycerides and "bad" cholesterol and other problems increasing the risk of diabetes, heart attack and stroke. There is growing acceptance of the notion that the body can adjust to even a heavy blockade of the CB1 system. Perhaps when the CB1 receptor is blocked, the endocannabinoids are redirected to other targets. At times the layman is struck by how rudimentary the biochemists' understanding of the body's mechanism of action really is. "We're on plateau one or two and the answer is on plateau 12," said Guy. "We could spend the next 30 years on receptors and still not fully understand them. When we talk about receptors and agonists and antagonists we should be talking in the same breath about functionality -real functionality, not models in non-pathological situations. We need an understanding of the clinical outcome." Americans who follow the medical marijuana movement may recall hearing of THC-V in the late 1990s, when the feds were trying to imprison would-be researcher Todd McCormick for violating a court order by ingesting marijuana (as opposed to Marinol). McCormick's criminality was proven by a pee test, specially designed by pharmacologist Mahmoud El Sohly to distinguish legal ingestion of pure, synthetic THC (Marinol) from illegal ingestion of herbal THC with its modulating compounds (THC-V et al). The THC-V test cost something like $15,000 to administer. The contrasting uses to which THC-V has been put by European and U.S. scientists says it all. Theirs are working towards understanding the plant and producing effective herbal medicines. Ours are working to develop keener tools for law-enforcement and strong, "pure" synthetics. Now let us contrast the Dutch and U.S. approaches towards coastline protection...
Goldberg's Monkeys Bat Last A researcher named Steven Goldberg maintains a colony of monkeys in Baltimore, Maryland that have been trained to self-administer THC (by injection). At this year's ICRS meeting Goldberg presented a poster co-authored by Zuzana Justinova on "The Abuse Potential of the Endocannbinoid Transport Inhibitor AM404: Self-Administration by Squirrel Monkeys." AM404 is one of the many compounds that corporate- and government-funded scientists are developing in hopes of achieving higher cannabinoid levels by indirect means. Goldberg's monkeys liked AM404 enough to self-administer it, which means, in NIDA's terms, that AM404 is a drug with potential for abuse. So, after all their efforts to create an alternative to the illegal herb, the drug companies will have to run their products by Goldberg's monkeys! The Goldberg-Justinova poster concluded "AM404 functioned as an effective reinforcer (comparable to THC, anadamide and cocaine under identical conditions) in non-human primates under a fixed-ratio schedule of drug injection. Our findings suggest that medications which promote the actions of endocannabinoids throughout the brain by inhibiting their membrane transport have a potential for abuse. It remains to be seen whether medications such as FAAH inhibitors, which augment CB1 signaling only in certain regions of the nervous system, would be self-administered in a similar manner." I'd always heard that monkeys couldn't be trained to self-administer THC, and mentioned this to Goldberg. Other researchers had used "Old World monkeys," he said, sounding somewhat disdainful, whereas he used squirrel monkeys from South America (as if our New World monkeys are inherently hipper). But the real key to his success, he added, was the very low doses with which he rewarded the monkeys. This made sense -most of the primates I know prefer a slight alteration of mood to getting knocked-out-loaded. It also resonated with a talk on neuroprotection by Italian investigators in which they found that a synthetic cannabinoid was beneficial only at the lowest concentrations tested, and detrimental at high concentrations. When the name of the game is The Cannabinoid System, less can be more. Fred Gardner can be reached at: fred@plebesite.com
|
from CounterPunch Books! The Case Against Israel By Michael Neumann ![]() Grand Theft Pentagon: Tales of Greed and Profiteering in the War on Terror by Jeffrey St. Clair ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
![]()
![]() ![]() ![]() ![]() ![]() |